Want to join the conversation?
$AMGN 2Q15 PR: Total revenues increased 4% versus 2Q14 to $5,370MM, with 6% product sales growth driven primarily by Enbrel, Prolia, Sensipar, Kyprolis and XGEVA. GAAP net income was $1,653MM compared to $1,547MM in 2Q14. GAAP EPS was $2.15 compared to $2.01 in 2Q14.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.